{
  "docId": "019de073-8079-71bb-b12b-cbebf2163a3a",
  "docSlug": "9b4d00e952721e20753466aee3e72db7",
  "documentTitle": "BenevolentAI | Investor Day Presentation Deck | 74 slides",
  "authorId": "benevolentai",
  "authorName": "BenevolentAI",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 25,
  "pageCount": 74,
  "prevPage": 24,
  "nextPage": 26,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 4,
  "notes": "The slide uses a list-based structure to demonstrate the value proposition and validation of the company's AI platform.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-8079-71bb-b12b-cbebf2163a3a/25",
  "deckHref": "/decks/019de073-8079-71bb-b12b-cbebf2163a3a",
  "deckJsonHref": "/decks/019de073-8079-71bb-b12b-cbebf2163a3a.json",
  "deckAnchorHref": "/decks/019de073-8079-71bb-b12b-cbebf2163a3a#slide-25",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.25,
        "x": 0.7,
        "y": 0.4
      },
      "kind": "image",
      "text": "The Lancet logo",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "69c97556-becf-45f9-93c1-6dd6542a526f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.2,
        "x": 0.7,
        "y": 0.7
      },
      "kind": "image",
      "text": "Eli Lilly logo",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ccfdf933-8192-4316-8825-affcca427504",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.6,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "list",
      "text": "NOVEL: Our technology and AI workflows identified a previously unknown antiviral mechanism. RAPID: The Benevolent Platform empowered scientists to rapidly formulate a hypothesis in just 48 hours. EFFECTIVE: Baricitinib shown to reduce mortality by 38% in hospitalised patients, and by 46% in ventilated or ECMO patients. FDA approved the use of baricitinib to treat COVID-19 in May 2022 after first granting emergency use authorisation for baricitinib in combination with remdesivir in Nov 2020.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9bc9152c-b247-4dc5-affd-b4c52a14f255",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.25,
        "x": 0.7,
        "y": 0.25
      },
      "kind": "paragraph",
      "text": "BenevolentAI published research in Feb 2020. Led to equity investment from Eli Lilly.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "561c75e4-2317-41dd-bb58-2b8bf613efae",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.05,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "Sources: (1) Richardson et al. Lancet 2020; (2) Marconi et al. Lancet Respiratory Medicine 2021; (3) Ely et al. Lancet Respiratory Medicine 2022; (4) Lilly press release 11 May 2022; (5) Lilly press release 19 Nov 2020",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "52a8d2bd-a214-43cd-9482-23684c975681",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.8,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Regulatory validation: identified a COVID-19 treatment now fully approved for use by the FDA",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e45df09b-ae24-4caf-a774-65dc1e3488b0",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 74,
      "from": 8,
      "beatId": "e075ee7a-56af-49ed-87dd-38efd7ca183a",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "The Benevolent Platform™: a versatile, scalable and proven AI-enabled R&D engine",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}